Send us a text

In this episode of Life Science Success, my guest is Gino Martini.  Gino is the CEO of the Precision Health Technologies Accelerator (PHTA Ltd).  Previously, he was the Chief Scientist of the Royal Pharmaceutical Society. 

Key Topics Covered: 

• Description of an accelerator program for health tech companies
• The importance of social interaction for innovation in a hybrid work environment
• Excitement for precision medicine and personalized treatment plans
• Interest in bedside manufacturing and its potential for patient care
• Challenges in the life sciences industry, such as the lack of lab space and access to skills
• Opportunities in precision medicine, bedside manufacturing, and the microbiome

Send us a text

• AJ Melet is the CEO of a startup biotechnology company Ronawk Inc.
• Ronawk Inc’s technology involves growing cells in a tissue mimetic substrate called bio blocks.
• The cells grow in 3D and form their own micro tissues, which can be used to manufacture new therapies.
• Roanoke's technology has potential applications in tissue engineering and scaling the production of biological factors.
• The biggest challenges Roanoke is currently facing are building a new lab and getting people to understand the new technology.
• AJ Melet is inspired by people who serve others, concerned about our ability to connect in a digital world, and excited by people tackling big challenges.

Send us a text

In this episode of Life Science Success, my guest is Katherine Vega Stultz.  Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients with end-stage liver disease.

In this episode of Life Science Success my guest is Katherine Vega Stultz and we touch upon a number of topics, including the non-linear path of career growth, the importance of being a generalist in a specialized industry, and the challenges and opportunities facing Ocelot Bio, a private venture-backed company that is focused on liver disease. Stultz talks about the importance of team collaboration, transparency, and communication, and how her experiences have helped her develop a continuous improvement mindset. She also discusses her passion for tackling complex problems that impact people's lives and how she is excited to be in a position of leadership that advocates for diversity and talent.

• Non-linear path of career growth
• Importance of being a generalist in a specialized industry
• Challenges and opportunities facing Ocelot Bio
• Importance of team collaboration, transparency, and communication
• Continuous improvement mindset
• Passion for tackling complex problems that impact people's lives
• Advocacy for diversity and talent in leadership

Send us a text

In this episode of the Life Science Success podcast, my guest is Martin-Immanuel Bittner 𝘔𝘋 𝘋𝘗𝘩𝘪𝘭 𝘍𝘙𝘚𝘈. Martin-Immanuel is the CEO & Co-Founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston.

Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company focused on drug discovery with partnerships worldwide. 

• Martin-Immanuel Bittner is the CEO and founder of Arctoris, a biotech platform company powered by robotics and machine learning based in Oxford and Boston
• The company's focus is on drug discovery, and it has partnerships with dozens of biotech and pharma companies worldwide
• The company is actively hiring and anticipates continued revenue growth and team growth in the coming years
• Bittner is excited about the continued drive towards having physiologically more relevant model systems
• Bittner sees AI and machine learning as powerful tools that will be increasingly adopted in a drug discovery context and predicts that all drugs reaching the market will have had some form of AI involvement in the future
• Bittner is concerned about human health being jeopardized by conflicts between different geopolitical blocks and the risk management that companies need to consider
• Bittner is excited about the transformation of the industry and the opportunities that lie ahead with new technologies and techniques that can bring more and better drugs to patients faster

Send us a text

In this episode of the Life Science Success podcast, my guest is Bremer Louw.  Bremer is the vice president of operations at Bioforum, a data focused CRO. He has been in the clinical research industry for over 15 years and has extensive experience in data management and biostatistics programming.

Bremer Louw, VP of Operations at Bioform, discusses the company's focus on meeting customer needs and building solutions for complex problems. He also expresses concerns about the pace of innovation and the ethical and regulatory implications of machine learning and artificial intelligence in the life sciences industry. Louw emphasizes the importance of small successes and momentum in achieving larger goals.

• Bioform is a smaller, more nimble organization with a different culture than larger companies like IQVIA.
• Bioform is attentive to customers' needs and works to meet them on an individual basis.
• Bremer Louw, the VP of Operations at Bioform, is responsible for overseeing operational metrics, professional services, quality, business development, and innovation.
• Bioform works with both drug and diagnostic companies.
• Louw is concerned about the pace of innovation in the industry and the ethical and regulatory implications of machine learning and artificial intelligence.
• Louw emphasizes the importance of small successes and momentum in achieving larger goals.

Send us a text

In this episode of Life Science Success my guest is Siddhartha Shrivastava, Ph.D.  Sidd is the 
Vice President, Head of CMC and Global Technical Operations at Cue Biopharma.  He is a proven leader and well-published scientific-technical operations professional with experience in leading research, early to late-stage process development, commercial launch, cGMP commercial manufacturing (DS/DP), due diligence of new targets and facility acquisition, end to end supply chain management, and CMO management for bio-therapeutic drugs.

Send us a text

In this episode of the Life Science Success Podcast my guest is Vadim Klyushnichenko, Ph.D,   Vadim is the VP Pharmaceutical Development at Scripps Research.  He has over 25 years of progressive experience in Global Bio/Pharmaceutical Development from Discovery to Clinical and Commercial Manufacturing.

Send us a text

In this episode of Life Science Success, my guest is Dr. Steven Fox.  Dr Fox is an experienced entrepreneur, doctor, educator and author.  He is also the founder and chairman of Akelos Inc. a biotechnology company developing non-addictive, non-opioid drugs for the treatment of neuropathic chronic pain.

Send us a text

This week on the Life Science Success Podcast my guest is Jae Yoo.  Jae is the Executive Director at EPM Scientific.  EPM Scientific exists to enable exceptional careers around the world. They connect exceptional talent, with exceptional opportunities.

Send us a text

This week on the Life Science Success Podcast my guest is Cristina Varner.  Cristina is the National Life Science and Digital Health & Telemedicine Practice Leader for Newfront.  She supports the risk management needs of biotech, medical device, pharmaceutical, diagnostic, digital health and telemedicine companies from early stage on up.